Literature DB >> 24569505

Low titer group O whole blood in emergency situations.

Geir Strandenes1, Olle Berséus, Andrew P Cap, Tor Hervig, Michael Reade, Nicolas Prat, Anne Sailliol, Richard Gonzales, Clayton D Simon, Paul Ness, Heidi A Doughty, Philip C Spinella, Einar K Kristoffersen.   

Abstract

In past and ongoing military conflicts, the use of whole blood (WB) as a resuscitative product to treat trauma-induced shock and coagulopathy has been widely accepted as an alternative when availability of a balanced component-based transfusion strategy is restricted or lacking. In previous military conflicts, ABO group O blood from donors with low titers of anti-A/B blood group antibodies was favored. Now, several policies demand the exclusive use of ABO group-specific WB. In this short review, we argue that the overall risks, dangers, and consequences of "the ABO group-specific approach," in emergencies, make the use of universal group O WB from donors with low titers of anti-A/B safer. Generally, risks with ABO group-specific transfusions are associated with in vivo destruction of the red blood cells transfused. The risk with group O WB is from the plasma transfused to ABO-incompatible patients. In the civilian setting, the risk of clinical hemolytic transfusion reactions (HTRs) due to ABO group-specific red blood cell transfusions is relatively low (approximately 1:80,000), but the consequences are frequently severe. Civilian risk of HTRs due to plasma incompatible transfusions, using titered donors, is approximately 1:120,000 but usually of mild to moderate severity. Emergency settings are often chaotic and resource limited, factors well known to increase the potential for human errors. Using ABO group-specific WB in emergencies may delay treatment because of needed ABO typing, increase the risk of clinical HTRs, and increase the severity of these reactions as well as increase the danger of underresuscitation due to lack of some ABO groups. When the clinical decision has been made to transfuse WB in patients with life-threatening hemorrhagic shock, we recommend the use of group O WB from donors with low anti-A/B titers when logistical constraints preclude the rapid availability of ABO group-specific WB and reliable group matching between donor and recipient is not feasible.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24569505     DOI: 10.1097/SHK.0000000000000150

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  11 in total

Review 1.  Optimal Fluid Therapy for Traumatic Hemorrhagic Shock.

Authors:  Ronald Chang; John B Holcomb
Journal:  Crit Care Clin       Date:  2017-01       Impact factor: 3.598

Review 2.  Remote Damage Control Resuscitation in Austere Environments.

Authors:  Ronald Chang; Brian J Eastridge; John B Holcomb
Journal:  Wilderness Environ Med       Date:  2017-06       Impact factor: 1.518

3.  ABO antibody titres: a multisite comparative study of equivalency and reproducibility for automated solid-phase and haemagglutination titration, and manual dilution with gel column agglutination technology.

Authors:  Dana Schneider; Mariangela Vicarioto; Serelina Coluzzi; Antonella Matteocci; Nicoletta Revelli; Barbara Foglieni; Patrizia Artusi; Donatella Londero; Anna Quaglietta; Giancarla Barrotta; Domenico Visceglie; Giuseppina Portararo; Jonella Gilsdorf
Journal:  Blood Transfus       Date:  2022-01-20       Impact factor: 5.752

4.  The use of whole blood in traumatic bleeding: a systematic review.

Authors:  Mario Cruciani; Massimo Franchini; Carlo Mengoli; Giuseppe Marano; Ilaria Pati; Francesca Masiello; Eva Veropalumbo; Simonetta Pupella; Stefania Vaglio; Vanessa Agostini; Giancarlo Maria Liumbruno
Journal:  Intern Emerg Med       Date:  2020-09-15       Impact factor: 3.397

5.  Modern resuscitation of hemorrhagic shock: what is on the horizon?

Authors:  D T Martin; M A Schreiber
Journal:  Eur J Trauma Emerg Surg       Date:  2014-06-17       Impact factor: 3.693

6.  Quality improvement with platelet additive solution for safer out-of-group platelet transfusions.

Authors:  Maxim Tynuv; Willy A Flegel
Journal:  Immunohematology       Date:  2019-09

Review 7.  Whole Blood for Resuscitation of Traumatic Hemorrhagic Shock in Adults.

Authors:  Allison R Jones; Justin L Miller; Jan O Jansen; Henry E Wang
Journal:  Adv Emerg Nurs J       Date:  2021 Oct-Dec 01

Review 8.  Whole Blood, Fixed Ratio, or Goal-Directed Blood Component Therapy for the Initial Resuscitation of Severely Hemorrhaging Trauma Patients: A Narrative Review.

Authors:  Mark Walsh; Ernest E Moore; Hunter B Moore; Scott Thomas; Hau C Kwaan; Jacob Speybroeck; Mathew Marsee; Connor M Bunch; John Stillson; Anthony V Thomas; Annie Grisoli; John Aversa; Daniel Fulkerson; Stefani Vande Lune; Lucas Sjeklocha; Quincy K Tran
Journal:  J Clin Med       Date:  2021-01-17       Impact factor: 4.241

9.  Is the whole greater than the sum of its parts? The implementation and outcomes of a whole blood program in Ecuador.

Authors:  Amber Himmler; Monica Eulalia Galarza Armijos; Jeovanni Reinoso Naranjo; Sandra Gioconda Peña Patiño; Doris Sarmiento Altamirano; Nube Flores Lazo; Raul Pino Andrade; Hernán Sacoto Aguilar; Lenin Fernández de Córdova; Cecibel Cevallos Augurto; Nakul Raykar; Juan Carlos Puyana; Juan Carlos Salamea
Journal:  Trauma Surg Acute Care Open       Date:  2021-11-18

10.  Transfusion: -80°C Frozen Blood Products Are Safe and Effective in Military Casualty Care.

Authors:  Femke Noorman; Thijs T C F van Dongen; Marie-Christine J Plat; John F Badloe; John R Hess; Rigo Hoencamp
Journal:  PLoS One       Date:  2016-12-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.